Literature DB >> 7789558

Fibroid growth in response to high-dose progestogen.

M Harrison-Woolrych1, R Robinson.   

Abstract

OBJECTIVE: To challenge the conventional belief that leiomyomata are estrogen-dependent tumors by presentation of a case report suggesting high-dose progestogen therapy is associated with a dramatic increase in size of a fibroid uterus.
DESIGN: Case report.
SETTING: British university hospital. PATIENT: One white woman treated with tamoxifen and high-dose megestrol acetate for breast carcinoma.
INTERVENTIONS: Megestrol acetate therapy withdrawn. MAIN OUTCOME MEASURE: Uterine size.
RESULTS: While taking tamoxifen and high-dose megestrol acetate, the patient suffered a dramatic increase in size of her fibroid uterus, which reversed when the progestogen was withdrawn.
CONCLUSION: This case report suggests that P may be important in fibroid growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789558

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

2.  Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.

Authors:  Eun Hee Kim; Joo Young Kim; Yoon Hee Lee; Gun Oh Chong; Ji Young Park; Dae Gy Hong
Journal:  Obstet Gynecol Sci       Date:  2014-03-15

Review 3.  A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.

Authors:  Terrence D Lewis; Minnie Malik; Joy Britten; Angelo Macapagal San Pablo; William H Catherino
Journal:  Biomed Res Int       Date:  2018-01-28       Impact factor: 3.411

4.  Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.

Authors:  Khaleque N Khan; Akira Fujishita; Akemi Koshiba; Kanae Ogawa; Taisuke Mori; Hiroshi Ogi; Kyoko Itoh; Satoshi Teramukai; Jo Kitawaki
Journal:  PLoS One       Date:  2020-11-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.